Label Changes for:
Eraxis (anidulafungin) Powder for Injection
July 2012
Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2012
WARNINGS AND PRECAUTIONS
Hypersensitivity
- bronchospasm
November 2010
ADVERSE REACTIONS
- General: bronchospasm

